# Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

> **NCT02745093** · PHASE4 · UNKNOWN · sponsor: **Ibis Reproductive Health** · enrollment: 648 (estimated)

## Conditions studied

- Medical Abortion

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT02745093
- **Lead sponsor:** Ibis Reproductive Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 648 (ESTIMATED)
- **Last updated:** 2016-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02745093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02745093, "Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02745093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*